Latest in Jump Demand Ozempic
Sort by
193 items
-
Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.The New York Times - 4h -
-
Novo Nordisk sales beat estimates, but the story wasn’t Ozempic
Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs.MarketWatch - 14h -
Will This New GLP-1 Drug be More Powerful Than Ozempic?
Investors seek answers on Novo Nordisk’s next-gen obesity drug, CagriSema.Inc. - 1d -
‘Before Ozempic we had amphetamines. But it’s always the same violence’: Coralie Fargeat on women, ageing and Hollywood
Her gruesome horror The Substance has won her multiple Oscar nominations – and given its star Demi Moore’s career new life. But did taking down the patriarchy have to be so gory?. Coralie Fargeat ...The Guardian - 2d -
Jump rope pro saves neighbor and dog from ice pond – with jump rope
David Fisher of Westfield, Indiana, and son Felix rescued man who had fallen in after trying to rescue dog. In an extreme instance of life imitating art, an author of children’s books about a ...The Guardian - 4d -
ASML shares jump 10% as surge in orders defies fears of DeepSeek hitting AI chip demand
Dutch semiconductor equipment maker ASML on Wednesday reported better-than-expected net sales and profit results for the fourth quarter.CNBC - Jan. 29 -
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.CNBC - Jan. 28 -
Bipartisan senators demand Trump explanation for IG firings
The leaders of the Senate Judiciary Committee sent a rare bipartisan letter to President Trump demanding an explanation for his firing of 17 inspectors general (IG) in one night. The rebuke said ...The Hill - Jan. 28 -
Democrats demand answers on Trump DOJ firings, reassignments
House Democratic leaders are asking Justice Department officials to explain an “onslaught” of firings and reassignments of prosecutors during President Trump’s first week in office. The letter from ...The Hill - Jan. 28 -
What drives gold prices more: Supply or demand?
Both supply and demand can affect the price of gold. But which one drives prices higher? Here's what experts think.CBS News - Jan. 27 -
Newark officials demand answers after ICE raid
Officials in Newark, along with immigrant rights activists, are criticizing a warrantless ICE raid targeting a New Jersey seafood business. Several people were detained during the operation.NBC News - Jan. 24 -
Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.
Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.MarketWatch - Jan. 24 -
'Costs just keep rising' - jump in firms in trouble
Businesses in the most distress include those in hospitality, leisure and retail, say insolvency specialists.BBC News - Jan. 24 -
Trump says he will 'demand' lower interest rates
Trump made a virtual address to the World Economic Forum in Davos, Switzerland.ABC News - Jan. 23 -
Netflix shares jump as it adds record number of subscribers
Streaming pioneer’s total number of customers passes 300mn as it receives boost from live sportsFinancial Times - Jan. 21 -
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.CNBC - Jan. 17 -
Ozempic picked for Medicare price bargaining
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden adds Ozempic to list for Medicare price negotiation In one of its last actions, the Biden administration ...The Hill - Jan. 17 -
Obesity drugs Ozempic and Wegovy included in US price-cut talks
Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiationsFinancial Times - Jan. 17 -
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.The Wall Street Journal - Jan. 17 -
White House says popular weight-loss drug Ozempic subject to Medicare talks
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.MarketWatch - Jan. 17 -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - Jan. 17 -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - Jan. 17 -
CMS to seek Medicare negotiations on Ozempic price
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...The Hill - Jan. 17 -
Swissquote Expects Results To Beat Views on Crypto Demand
The online bank said its results for 2024 should exceed market expectations as it was boosted by cryptocurrency trading.The Wall Street Journal - Jan. 17 -
How Ozempic Has Forever Changed How Much People Spend on Food, According to a New Cornell University Study
Ozempic doesn’t just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food they buy.Inc. - Jan. 16 -
Relative of Jack the Ripper victim demands new inquest
The true identity of Jack the Ripper, whose grisly murders terrorized east London in 1888, has been a mystery ever since.CBS News - Jan. 13 -
‘Will Pay Any Amount’: Private Firefighters Are in Demand in L.A.
Hiring a private fire crew costs thousands of dollars a day, and most work through government contracts or with insurance companies. Some wealthy property owners are calling them in directly.The New York Times - Jan. 13 -
Lululemon’s stock jumps as strong holiday sales show demand is improving
Lululemon’s stock rallies toward a 10-month high after guidance for profit, revenue and gross margin were raised.MarketWatch - Jan. 13 -
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?Wired - Jan. 13 -
Baby boomers and ‘Ozempic face’ drive injectables craze
People ‘want to look what they feel like, not what they may look like’ says dermatology giant GaldermaFinancial Times - Jan. 12 -
Emma Raducanu bitten by jumping ants
Emma Raducanu has become the latest victim of Australia’s famously hostile wildlife – although it was not spiders or snakes in her case, but rather “jumping ants”.Yahoo Sports - Jan. 10 -
'High demand' for City of Culture opening ceremony
'High demand' reported for open-air performance in Bradford city centre on Friday.BBC News - Jan. 10 -
Rebels issue demand for RFU chief Sweeney sacking
The crisis at the top of English rugby erupts as rebels call for a final confrontation over Rugby Football Union's embattled chief executive Bill SweeneyBBC News - Jan. 9 -
How Trump’s Greenland Plan Could Hit Ozempic, Legos and Hearing Aids
Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular medicines.The New York Times - Jan. 9 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9 -
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...MarketWatch - Jan. 8 -
Will Pat Riley and the Heat bend to Jimmy Butler's demands?
The Heat star wants out of Miami. But what is it that he wants? The answer is obvious.Yahoo Sports - Jan. 7 -
Eurozone inflation jumps to 2.4% in third consecutive rise
Increase damps hope that European Central Bank will boost region’s flagging economy with rate cutsFinancial Times - Jan. 7
